OPTHF (Optimi Health) Debt-to-EBITDA : -0.76 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Optimi Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Optimi Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $0.70 Mil. Optimi Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $1.26 Mil. Optimi Health's annualized EBITDA for the quarter that ended in Dec. 2024 was $-2.59 Mil. Optimi Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was -0.76.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Optimi Health's Debt-to-EBITDA or its related term are showing as below:

OPTHF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.36 Med: -0.21 Max: -0.02
Current: -1.36

During the past 5 years, the highest Debt-to-EBITDA Ratio of Optimi Health was -0.02. The lowest was -1.36. And the median was -0.21.

OPTHF's Debt-to-EBITDA is ranked worse than
100% of 679 companies
in the Drug Manufacturers industry
Industry Median: 1.62 vs OPTHF: -1.36

Optimi Health Debt-to-EBITDA Historical Data

The historical data trend for Optimi Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health Debt-to-EBITDA Chart

Optimi Health Annual Data

Trend

Sep20

Sep21

Sep22

Sep23

Sep24

Debt-to-EBITDA

N/A

-0.04

-0.02

-0.39

-0.58

Optimi Health Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
Debt-to-EBITDA	Get a 7-Day Free Trial												-0.35	-0.67	-0.59	N/A	-0.76

Competitive Comparison of Optimi Health's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimi Health's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimi Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Optimi Health's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Optimi Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Optimi Health's Debt-to-EBITDA for the fiscal year that ended in Sep. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.733	+	1.299)	/	-3.498
	=	-0.58

Optimi Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(0.702	+	1.256)	/	-2.588
	=	-0.76

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.

Optimi Health (OTCPK:OPTHF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Optimi Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Optimi Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimi Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (OTCPK:OPTHF) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

8BN:Germany OPTI:Canada

Address

21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1

Website

https://www.optimihealth.ca

Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.